$1.84
+0.0800 (+4.55%)
At Close: Jun 03, 2026
iBio Inc. (IBIO) Rises From The Low: Could It Be A Catbird Seat?
01:00pm, Thursday, 23'rd Dec 2021 Stocks Register
iBio Inc. (AMEX:IBIO) concluded the trading at $0.66 on Wednesday, December 22 with a rise of 1.54% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.65 and 5Y monthly beta was reading -6.24 with its price kept floating in the range iBio Inc. (IBIO) Rises From The Low: Could It Be A Catbird Seat? Read More »
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
02:25pm, Wednesday, 22'nd Dec 2021 GlobeNewswire Inc.
- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Marg
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
02:25pm, Wednesday, 22'nd Dec 2021 Intrado Digital Media
- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -
iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting
02:20pm, Tuesday, 21'st Dec 2021 GlobeNewswire Inc.
BRYAN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-bas
Valuing Stock Using Ratios and Multiples: Histogen Inc. (NASDAQ:HSTO), iBio, Inc. (AMEX:IBIO)
12:53am, Monday, 20'th Dec 2021 Stock Equity
Histogen Inc. (NASDAQ:HSTO) with the stream of 2.34% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of 6.16% in the last hour of Fridays trading session. Histogen Inc. The post Valuing Stock Using Ratios and Multiples: Histogen Inc. (NASDAQ:HSTO), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
iBio Inc.s (AMEX: IBIO) Stock Price Continues To Fall
12:00pm, Wednesday, 15'th Dec 2021 Stocks Register
The trading price of iBio Inc. (AMEX:IBIO) closed lower on Tuesday, December 14, closing at $0.65, -2.29% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy
Captivating Stock: Tuniu Corporation (NASDAQ:TOUR), iBio, Inc. (AMEX:IBIO)
12:19am, Wednesday, 15'th Dec 2021 Stock Equity
Tuniu Corporation (NASDAQ:TOUR) with the stream of -1.32% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of -2.29% in the last hour of Tuesdays trading session. Tuniu Corporation The post Captivating Stock: Tuniu Corporation (NASDAQ:TOUR), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
Tuniu Corporation, NASDAQ:TOUR, TOUR NEWS, TOUR STOCK, iBio, Inc., AMEX:IBIO, IBIO NEWS, IBIO STOCK, TOUR, IBIO
12:19am, Wednesday, 15'th Dec 2021 Stock Equity
Cyren Ltd. (NASDAQ:CYRN) with the stream of -5.83% also noticed, India IT Tech Packaging, Inc. (AMEX:ITP) encountered a rapid change of -2.38% in the last hour of Tuesdays trading session. The post Tuniu Corporation, NASDAQ:TOUR, TOUR NEWS, TOUR STOCK, iBio, Inc., AMEX:IBIO, IBIO NEWS, IBIO STOCK, TOUR, IBIO appeared first on Stocks Equity .
iBio Inc. (AMEX: IBIO): Blank Check On Growth?
05:10pm, Friday, 10'th Dec 2021 Stocks Register
iBio Inc. (AMEX:IBIO) price on Friday, December 10, fall -4.06% below its previous days close as a downside momentum from buyers pushed the stocks value to $0.67. A look at the stocks price movement, the level at last check in todays session was $0.69, moving within a range at $0.69 and $0.75. The beta value iBio Inc. (AMEX: IBIO): Blank Check On Growth? Read More »
iBio Announces Partial Adjournment of Annual Meeting to December 22
01:30pm, Friday, 10'th Dec 2021 GlobeNewswire Inc.
- Shareholders Presently Supporting Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -
Technology - IBio Upgraded to Hold by Zacks Investment Research
08:45am, Tuesday, 07'th Dec 2021 Business Mag
Zacks Investment Research upgraded shares of iBio from a sell rating to a hold rating in a research report released on Monday morning, Zacks.com reports. According to Zacks
iBio (NYSEAMERICAN:IBIO) Upgraded to Hold by Zacks Investment Research
05:08am, Tuesday, 07'th Dec 2021 Dakota Financial News
iBio (NYSEAMERICAN:IBIO) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a research note issued on Monday, Zacks.com reports. According to Zacks, Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. []
iBio Inc. Shares Close the Day 12.7% Lower - Daily Wrap
10:47pm, Tuesday, 30'th Nov 2021 Kwhen Finance
iBio Inc. (IBIO) shares closed today 12.7% lower than it did at the end of yesterday. The stock is currently down 18.7% year-to-date, down 43.5% over the past 12 months, and down 81.4% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.2%. Trading Activity Shares traded as high as $0.98 and as low as $0.56 this week.Shares closed 73.7% below its 52-week high and 33.0% above its 52-week low.Trading volume this week was 296.5% higher than the 10-day average and 577.6% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -41.5% The company's stock price performance over the past 12 months lags the peer average by 66.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Hot Biotech Penny Stocks to Buy Today? 3 For Your December Watchlist
02:13pm, Tuesday, 30'th Nov 2021 PennyStocks
Trading biotech penny stocks right now? Check these three out
The post Hot Biotech Penny Stocks to Buy Today? 3 For Your December Watchlist appeared first on Penny Stocks to Buy, Picks, News and Infor
ISS Joins Glass Lewis in Recommending Shareholders Vote “FOR” All Proposals Ahead of iBio’s Upcoming Annual Meeting
01:00pm, Tuesday, 30'th Nov 2021 GlobeNewswire Inc.
- iBio’s Board Urges Shareholders to Vote Today to Support Company’s Strategic Growth Plans -
Sign In
Buy IBIO